Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders | MicrobiomeTrials← Back to trialsNCT05064319
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2022-02-24Est. Completion: 2026-07-31
Enrollment target: 51 participants Locations- Medical University Of South Carolina, Charleston, South Carolina, United States
Other microbiome trials you might be interested in
Bipolar Disorder
This study looks to identify genes that may affect a person's chances of developing bipolar disorder (BP) and related co…
Bethesda, United States
Healthy, Non-Drug- Dependent, Recreational Opioid Users
The purpose of the present study is to assess prospectively the abuse potential of gabapentin when taken with and withou…
Overland Park, United StatesEst. completion Jan 31, 2027
Recruiting
Metastatic Castration-resistant Prostate Cancer
This is an open-label, single-arm phase II study of bipolar androgen therapy (BAT) given in addition with standard of ca…
New Haven, United StatesEst. completion Dec 2027